Cellectis S.A. (LON:0WA2)

Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of GBP 185.26 million. The enterprise value is 208.61 million.

Market Cap	185.26M
Enterprise Value	208.61M

Important Dates

The next estimated earnings date is Friday, November 7, 2025.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	72.33M
Shares Outstanding	n/a
Shares Change (YoY)	+41.82%
Shares Change (QoQ)	-1.25%
Owned by Insiders (%)	2.20%
Owned by Institutions (%)	11.19%
Float	41.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.00
PB Ratio	2.61
P/TBV Ratio	2.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.84
EV / Sales	4.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.08

Financial Position

The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.94.

Current Ratio	1.38
Quick Ratio	0.53
Debt / Equity	0.94
Debt / EBITDA	n/a
Debt / FCF	-2.57
Interest Coverage	-5.80

Financial Efficiency

Return on equity (ROE) is -48.02% and return on invested capital (ROIC) is -13.26%.

Return on Equity (ROE)	-48.02%
Return on Assets (ROA)	-7.43%
Return on Invested Capital (ROIC)	-13.26%
Return on Capital Employed (ROCE)	-24.24%
Revenue Per Employee	211,431
Profits Per Employee	-196,630
Employee Count	222
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

In the past 12 months, Cellectis has paid 332,105 in taxes.

Income Tax	332,105
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +69.98% in the last 52 weeks. The beta is 3.04, so Cellectis's price volatility has been higher than the market average.

Beta (5Y)	3.04
52-Week Price Change	+69.98%
50-Day Moving Average	2.95
200-Day Moving Average	1.90
Relative Strength Index (RSI)	44.92
Average Volume (20 Days)	8,619

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cellectis had revenue of GBP 46.30 million and -43.06 million in losses. Loss per share was -0.44.

Revenue	46.30M
Gross Profit	46.30M
Operating Income	-33.00M
Pretax Income	-42.73M
Net Income	-43.06M
EBITDA	-24.11M
EBIT	-33.00M
Loss Per Share	-0.44

Balance Sheet

The company has 43.65 million in cash and 66.40 million in debt, giving a net cash position of -22.74 million.

Cash & Cash Equivalents	43.65M
Total Debt	66.40M
Net Cash	-22.74M
Net Cash Per Share	n/a
Equity (Book Value)	70.88M
Book Value Per Share	0.98
Working Capital	46.14M

Cash Flow

In the last 12 months, operating cash flow was -24.34 million and capital expenditures -1.48 million, giving a free cash flow of -25.82 million.

Operating Cash Flow	-24.34M
Capital Expenditures	-1.48M
Free Cash Flow	-25.82M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -71.28% and -93.00%.

Gross Margin	100.00%
Operating Margin	-71.28%
Pretax Margin	-92.28%
Profit Margin	-93.00%
EBITDA Margin	-52.08%
EBIT Margin	-71.28%
FCF Margin	n/a

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.82%
Shareholder Yield	-41.82%
Earnings Yield	-23.24%
FCF Yield	-13.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellectis has an Altman Z-Score of -0.95 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.95
Piotroski F-Score	3